| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.32 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |